Walmart has already seen a 'a slight pullback' from customers on weight loss drugs, executives say.
As weight loss drugs like Ozempic face possible connection to stomach paralysis, retailers are hoping the news will lead consumers to an uptick in grocery spending.Walmart's chief executive warned of the change in food shopping habits for those taking Ozempic earlier this month. As inflation remains high and Americans continue to reel in their spending, the appetite suppressants have caused some retail leaders to become even more concerned over their bottom line.
This likely will see those reduce their diets by 20 percent fewer calories.Junk food as a whole could see its market value plummet, with analysts theorizing that soda, baked goods and salty snack consumption could wane by 3 percent.Weight Loss Drugs Linked to Health RisksThere could be one beacon of hope for retailers seeing food purchases go down, however. As more research is invested in weight loss drugs, some scientists have sounded the alarms on several worrying potential side effects.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Ozempic and Wegovy Can Cause 3 Severe Stomach Conditions, New Study SaysDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Baca lebih lajut »
Ozempic May Be Causing Walmart Food Sales to Drop, CEO SaysYour ultimate source for expert nutrition tips and health advice, covering wellness, healthy recipes, cooking hacks, food news, style trends and shopping.
Baca lebih lajut »
Study Confirms Risk of Gastro Issues for People Taking Wegovy, OzempicWhile many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.
Baca lebih lajut »
Ozempic craze sends beer and snack stocks plummetingToday's Business Headlines: 10\/6\/23
Baca lebih lajut »
Ozempic-like meds linked to higher risk of pancreatitis, 'stomach paralysis' than other weight-loss drugsNicoletta Lanese is the health channel editor at Live Science and was previously a news editor and staff writer at the site. She holds a graduate certificate in science communication from UC Santa Cruz and degrees in neuroscience and dance from the University of Florida. Her work has appeared in The Scientist, Science News, the Mercury News, Mongabay and Stanford Medicine Magazine, among other outlets. Based in NYC, she also remains heavily involved in dance and performs in local choreographers' work.
Baca lebih lajut »